Clinical Trials Directory

Trials / Completed

CompletedNCT00455026

Effect of Remifentanil on Electroencephalographic BAR Index During Propofol Anaesthesia

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Melbourne Health · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Current cortical EEG based depth of anaesthesia monitors do not accurately reflect the effect of opioid drugs. We have developed a new theoretically-based method of analysing the EEG. Our hypothesis is that this new method will more accurately predict depth of anaesthesia than the Bispectral Index (BIS) monitor in patients having elective surgery.

Detailed description

Patients aged 18-60 years presenting for elective surgery under general anaesthesia will be recruited. They will be randomised to receive remifentanil effect-site target 0, 2 or 4 ng/ml. Then anaesthesia will be induced with propofol. Loss of the eyelash reflex, response to command and response to electrical stimulation will be measured. The raw EEG will be recorded and analysed off-line using our new method and also for BIS values. Anaesthesia will then proceed according to the needs of the patient and the surgery.

Conditions

Interventions

TypeNameDescription
DRUGremifentaniltarget effect site concentration during induction

Timeline

Start date
2006-03-01
Primary completion
2007-10-01
Completion
2007-10-01
First posted
2007-04-03
Last updated
2013-05-30

Locations

2 sites across 1 country: Australia

Source: ClinicalTrials.gov record NCT00455026. Inclusion in this directory is not an endorsement.